From the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells.

[1]  S. Miyano,et al.  Frequent Genetic Alterations in Immune Checkpoint-Related Genes in Intravascular Large B-Cell Lymphoma. , 2020, Blood.

[2]  Yicheng Zhu,et al.  Prognosis of Intravascular Large B Cell Lymphoma (IVLBCL): Analysis of 182 Patients from Global Case Series , 2020, Cancer management and research.

[3]  W. Chuang,et al.  Intravascular Large B-cell lymphoma: A case series and review of literatures , 2020, Biomedical journal.

[4]  Qingjiao Li,et al.  EBV-positive intravascular large B-cell lymphoma of the liver: a case report and literature review , 2020, Diagnostic Pathology.

[5]  Hiroki Kobayashi,et al.  Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years , 2019, British journal of haematology.

[6]  E. Campo,et al.  Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. , 2018, Blood.

[7]  Jinjun Cheng,et al.  Recurrent Cytogenetic Abnormalities in Intravascular Large B-Cell Lymphoma , 2018, American journal of clinical pathology.

[8]  M. Kersten,et al.  High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. , 2018, Blood.

[9]  S. Nand,et al.  Intravascular Large B-Cell Lymphoma , 2014, Journal of investigative medicine high impact case reports.

[10]  M. Kashimura.  A CD13- and CD5-positive Asian variant of an intravascular large B cell lymphoma with a highly aggressive leukemic picture , 2011, Annals of Hematology.

[11]  I. Savvidou,et al.  Intravascular B‐cell lymphoma with leukemic presentation: case report and literature review , 2007, European journal of haematology.

[12]  E. Campo,et al.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  E. Campo,et al.  Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. , 2007, Haematologica.

[14]  T. Yoshino,et al.  Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. , 2007, Blood.

[15]  Takashi Miyoshi,et al.  Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy , 2006, International journal of hematology.

[16]  A. López-Guillermo,et al.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 , 2004, British journal of haematology.

[17]  R. Gascoyne,et al.  Multicolor Karyotyping and Clinicopathological Analysis of Three Intravascular Lymphoma Cases , 2003, Modern Pathology.

[18]  K. Ohshima,et al.  Analysis of the immunoglobulin heavy chain gene variable region of intravascular large B-cell lymphoma , 2001, Virchows Archiv.

[19]  G. Arrigoni,et al.  Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. , 2000, Human pathology.

[20]  L. Medeiros,et al.  Intravascular large B-cell lymphoma: A report of five cases initially diagnosed by bone marrow biopsy , 1999 .

[21]  L. Medeiros,et al.  Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  J. Tappeiner,et al.  [On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis?]. , 1959, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.